{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:13:43Z","timestamp":1773929623540,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673771"],"award-info":[{"award-number":["81673771"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001206"],"award-info":[{"award-number":["82001206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Province Department of Science and Technology","doi-asserted-by":"publisher","award":["BE2016809"],"award-info":[{"award-number":["BE2016809"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX22_0750"],"award-info":[{"award-number":["SJCX22_0750"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX22_1899"],"award-info":[{"award-number":["KYCX22_1899"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.labinv.2025.104266","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:57:52Z","timestamp":1764086272000},"page":"104266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and Multidimensional Characterization of a Novel Epstein-Barr Virus (EBV)\u2013Negative Human Type I Natural Killer T-Cell Line NKT617"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-4596","authenticated-orcid":false,"given":"Chencheng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reaila","family":"Jianati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-0774.2010.00087.x","article-title":"History of leukemia-lymphoma cell lines","volume":"23","author":"Drexler","year":"2010","journal-title":"Hum Cell"},{"issue":"8","key":"10.1016\/j.labinv.2025.104266_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/cancers11081098","article-title":"Cancer cell lines are useful model systems for medical research","volume":"11","author":"Mirabelli","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.labinv.2025.104266_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/hsz-2017-0321","article-title":"Hodgkin lymphoma cell lines: to separate the wheat from the chaff","volume":"399","author":"Drexler","year":"2018","journal-title":"Biol Chem"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4049\/jimmunol.134.3.1623","article-title":"TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells)","volume":"134","author":"Yodoi","year":"1985","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104266_bib5","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib6","first-page":"406","article-title":"Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia","volume":"24","author":"Robertson","year":"1996","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2141.1998.01029.x","article-title":"Establishment of an IL-2-dependent cell line derived from \u2018nasal-type\u2019 NK\/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus","volume":"103","author":"Kagami","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104266_bib8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.V92.4.1374","article-title":"Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma\/leukemia associated with Epstein-Barr virus infection","volume":"92","author":"Tsuchiyama","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.labinv.2025.104266_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/sj.leu.2401769","article-title":"A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation","volume":"14","author":"Yagita","year":"2000","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1182\/blood.V97.3.708","article-title":"Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T\/NK-cell lymphomas associated with the Epstein-Barr virus","volume":"97","author":"Nagata","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.labinv.2025.104266_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0145-2126(02)00023-1","article-title":"Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens","volume":"26","author":"Matsuo","year":"2002","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0145-2126(03)00254-6","article-title":"A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization","volume":"28","author":"Chen","year":"2004","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.labinv.2025.104266_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ijc.11647","article-title":"Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia","volume":"108","author":"Daibata","year":"2004","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.159.3.1200","article-title":"Involvement of protein tyrosine kinase p72syk and phosphatidylinositol 3-kinase in CD2-mediated granular exocytosis in the natural killer cell line, NK3.3","volume":"159","author":"Umehara","year":"1997","journal-title":"J Immunol"},{"issue":"11-12","key":"10.1016\/j.labinv.2025.104266_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3727\/096368911X580536","article-title":"Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line","volume":"20","author":"Cheng","year":"2011","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.labinv.2025.104266_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40425-019-0612-2","article-title":"Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy","volume":"7","author":"Yang","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.labinv.2025.104266_bib17","first-page":"731","article-title":"Establishment and characterization of a CD20-positive NK\/T-cell lymphoma cell line","volume":"61","author":"Gu","year":"2015","journal-title":"Clin Lab"},{"key":"10.1016\/j.labinv.2025.104266_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.leukres.2017.09.007","article-title":"Establishment of cell line with NK\/NKT phenotype from myeloid NK cell acute leukemia","volume":"61","author":"Darji","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.labinv.2025.104266_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2023.11.006","article-title":"Establishment of ganglioside GD2-expressing extranodal NK\/T-cell lymphoma cell line with scRNA-seq analysis","volume":"130","author":"Sato","year":"2024","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104266_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02647.x","article-title":"Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11","volume":"122","author":"Montoya","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.labinv.2025.104266_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molimm.2018.09.023","article-title":"The ins and outs of type I iNKT cell development","volume":"105","author":"Shissler","year":"2019","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.labinv.2025.104266_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.leu.2401778","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.labinv.2025.104266_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fimmu.2017.00533","article-title":"Chimeric antigen receptor-engineered NK-92 cells: an off-the-shelf cellular therapeutic for targeted elimination of cancer cells and induction of protective antitumor immunity","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.labinv.2025.104266_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12016-024-08998-0","article-title":"CAR-NKT cells in asthma: use of NKT as a promising cell for CAR therapy","volume":"66","author":"Taheri","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.labinv.2025.104266_bib25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3389\/fimmu.2019.01380","article-title":"Porcine invariant natural killer T cells: functional profiling and dynamics in steady state and viral infections","volume":"10","author":"Sch\u00e4fer","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104266_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ejh.13170","article-title":"NKT cells\u2014new players in CAR cell immunotherapy?","volume":"101","author":"Kriegsmann","year":"2018","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104266_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.tp.0000252783.66886.f3","article-title":"Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity","volume":"83","author":"Ilan","year":"2007","journal-title":"Transplantation"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372500176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372500176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:10:49Z","timestamp":1773918649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372500176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S002368372500176X"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104266","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and Multidimensional Characterization of a Novel Epstein-Barr Virus (EBV)\u2013Negative Human Type I Natural Killer T-Cell Line NKT617","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104266"}}